Analyst Ratings for UroGen Pharma (URGN) [Sells]
URGN Rating Summary
URGN Price Target Summary
- Highest: $54.00 (H.C. Wainwright)
- Lowest: $18.00 (Goldman Sachs)
- Average: $35.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$35.33 (+143.2%)
* Over Last 12-Mos
Rating Score: 6.4 / 10 Percentile Rank: 69%
Rating Score: 6.4 / 10 Percentile Rank: 69%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|